By
Jeffrey Bigongiari
Published: Jan. 31, 2013, 6:28 p.m.·
Tags:
None
With shortages of isoniazid, a major treatment for tuberculosis, expected to continue, the U.S. Centers for Disease Control and Prevention has expanded its general guidance to clinicians on how to adjust to a lack of the drug.
Read More →